Market research
MLZ.F MediPharm Labs Corp
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 19M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.93
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA58504D1006
- Market cap
- 19M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.93
About
About MediPharm Labs Corp
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the MLZ.F discussion.
5 years, 5 months ago
MediPharm Labs Corp is currently in a long term downtrend where the price is trading 24.5% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
MediPharm Labs Corp's total revenue sank by 84.8% to $5M since the same quarter in the previous year.
Its net income has dropped by 364.7% to $-15M since the same quarter in the previous year.
Finally, its free cash flow grew by 11.8% to $-7M since the same quarter in the previous year.
Based on the above factors, MediPharm Labs Corp gets an overall score of 2/5.